GAPDH and carcinoma: Metabolomic studies have been conducted in breast [17] and colorectal [18] carcinoma cells following administration of high-dose vitamin C. These studies consistently demonstrated an accumulation of metabolites upstream of glyceraldehyde 3-phosphate dehydrogenase (GAPDH) within the glycolytic pathway.